Lupin Pharmaceuticals develops and manufactures branded and generic pharmaceutical products for healthcare professionals and patients in India and the United States. It offers generic pharmaceutical products in the areas of oral and injectable cephalosporins; cardiovascular; controlled release ANDA's; and paragraph IV's. The company was founded in 2003 and is based in Baltimore, Maryland. It has plants in Mandideep, Aurangabad, Tarapur, Ankleshwar, and Goa, India; and Thailand.